Q3 2024 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-11-14 · accession 0001214659-24-019123
$385.8M
Reported value
17
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91529Y106 | UNM | UNUM GROUP | $57.3M | 14.9% | 964,170 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $46.6M | 12.1% | 651,710 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $45.7M | 11.8% | 131,926 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $24.7M | 6.40% | 71,704 | Common | SOLE |
| 16359R103 | CHE | CHEMED CORP NEW | $23.7M | 6.14% | 39,422 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $22.9M | 5.93% | 641,255 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $21.2M | 5.50% | 543,843 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $17.1M | 4.42% | 61,327 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $16.8M | 4.37% | 531,630 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $16.8M | 4.35% | 441,821 | Common | SOLE |
| 08579W103 | BERYEUR | BERRY GLOBAL GROUP INC | $16.7M | 4.32% | 244,982 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $16.0M | 4.15% | 67,582 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $15.4M | 3.98% | 316,556 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $14.5M | 3.77% | 930,507 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $12.2M | 3.17% | 192,889 | Common | SOLE |
| G97822103 | PRGO | PERRIGO CO PLC | $11.9M | 3.07% | 452,221 | Common | SOLE |
| 15687V109 | CERT | CERTARA INC | $6.3M | 1.64% | 541,830 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.